Kovack Advisors’s 60 Degrees Pharmaceuticals SXTP Stock Holding History

Kovack Advisors’s Portfolio SXTP Stock Details SXTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.4K	Buy	+15,000	New	+$24.1K	﹤0.01%	1066

Other funds holding SXTP

KCM

Kathmere Capital Management Wayne, Pennsylvania $1.89B AUM 26.04% 1-Year Est. Return

Kovack Advisors's SXTP Position: Q2 2026 in Review

Kovack Advisors opened a new position in 60 Degrees Pharmaceuticals (SXTP) in Q2 2026: 15,000 shares worth $26.4K. The stake represents ﹤0.01% of the portfolio and ranks #1066 among its holdings.

2 funds tracked by Wall St. Rank hold SXTP as of Q2 2026.

Kovack Advisors held 15,000 shares of 60 Degrees Pharmaceuticals worth $26.4K as of Q2 2026.
60 Degrees Pharmaceuticals was a new Kovack Advisors position in Q2 2026.
60 Degrees Pharmaceuticals made up ﹤0.01% of Kovack Advisors's portfolio in Q2 2026, its #1066 holding.
2 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals as of Q2 2026.

Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.